Results 171 to 180 of about 4,690 (200)

P151 Pregnancies with elexacaftor/tezacaftor/ivacaftor in Argentina

Journal of Cystic Fibrosis, 2023
E. Baran, L. Osken, N. Bergas Gimbernat
openaire   +1 more source

Early insurance coverage of elexacaftor/tezacaftor/ivacaftor for cystic fibrosis

Pediatric Pulmonology, 2021
Ashlee Anderson, Lindsey McCoy, Rebecca S. Pettit, Brittany A. Wright, Lisa Lubsch   +4 more
openaire   +2 more sources

Reported Adverse Events in a Multicenter Cohort of Patients Ages 6-18 Years with Cystic Fibrosis and at Least one F508del Allele Receiving Elexacaftor/Tezacaftor/Ivacaftor.

Jornal de Pediatria
OBJECTIVE To describe reported adverse events (AEs) associated with elexacaftor/tezacaftor/ivacaftor (ETI) in a pediatric sample with cystic fibrosis (CF) aged 6-18 years, with at least one F508del variant, followed at multiple Italian CF centers ...
V. Terlizzi, C. Fevola, S. Presti, A. Castaldo, V. Daccò, L. Claut, A. Sepe, F. Majo, R. Casciaro, I. Esposito, P. Vitullo, M. Salvi, P. Troiani, F. Ficili, G.F. Parisi, S. Pantano, S. Costa, G. Leonetti, N. Palladino, G. Taccetti, P. Bonomi, D. Salvatore   +21 more
semanticscholar   +1 more source

Clinical Effectiveness of Elexacaftor/Tezacaftor/Ivacaftor in People with Cystic Fibrosis: A Clinical Trial

American Journal of Respiratory and Critical Care Medicine, 2022
David P Nichols, Sonya L Heltshe, Scott H Donaldson   +2 more
exaly  

Elexacaftor/tezacaftor/ivacaftor no tratamento da fibrose cística

2023
João Mateus de Oliveira Rodrigues, Cleber Jose da Silva   +1 more
openaire   +1 more source

Efficacy and safety of elexacaftor plus tezacaftor plus ivacaftor versus tezacaftor plus ivacaftor in people with cystic fibrosis homozygous for F508del-CFTR: a 24-week, multicentre, randomised, double-blind, active-controlled, phase 3b trial

Lancet Respiratory Medicine,the, 2022
Sivagurunathan Sutharsan, Edward F Mckone, Damian G Downey   +2 more
exaly  

Efficacy of Elexacaftor/Tezacaftor/Ivacaftor in Advanced Cystic Fibrosis Lung Disease

Annals of the American Thoracic Society, 2021
Amir Reza Djavid, Alison E. Thompson, Alexandria L. Irace, Elen Gusman, Kimberly Altman, Emily A. DiMango, Claire L. Keating   +6 more
openaire   +2 more sources

Improvement in Lung Clearance Index and Chest Computed Tomography Scores with Elexacaftor/Tezacaftor/Ivacaftor Treatment in People with Cystic Fibrosis Aged 12 Years and Older – The RECOVER Trial

American Journal of Respiratory and Critical Care Medicine, 2023
Paul McNally, Edward McKone
exaly  

Positive and negative impacts of elexacaftor/tezacaftor/ivacaftor: Healthcare providers' observations across US centers

Pediatric Pulmonology, 2023
C.J. Bathgate, PhD, Emily F Muther, Anna M Georgiopoulos   +2 more
exaly  

Longitudinal Effects of Elexacaftor/Tezacaftor/Ivacaftor

CHEST
Sonia Graziano, Francesca Boldrini, Gaia Romana Pellicano, Francesco Milo, Fabio Majo, Luca Cristiani, Enza Montemitro, Federico Alghisi, Sergio Bella, Renato Cutrera, Alessandro Giovanni Fiocchi, Alexandra Quittner, Paola Tabarini   +12 more
openaire   +1 more source